View Older Stories

May 15, 2026 03:10AM Piper Sandler Downgrades Tango Therapeutics Inc. (TNGX) to Neutral

May 14, 2026 04:13PM Tango Therapeutics Inc. (TNGX) PT Raised to $30 at Mizuho

May 14, 2026 02:40PM Tango Therapeutics Inc. (TNGX) PT Raised to $55 at Leerink Partners

May 14, 2026 02:53AM Jefferies Downgrades Tango Therapeutics Inc. (TNGX) to Hold

May 13, 2026 04:08PM Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 1c

May 4, 2026 02:27PM Tango Therapeutics, Inc (TNGX) May 23 and 30 calls active, share price up 10%

Apr 28, 2026 02:37PM Tango Therapeutics, Inc (TNGX) 2900 contracts of June 30 calls trade, share price down 5.5%

Apr 27, 2026 07:30AM Tango Therapeutics Inc. (TNGX) PT Raised to $40 at Stifel on Higher PRMT5 Inhibitor Conviction

Apr 20, 2026 12:17PM Stifel on Tango Therapeutics Inc. (TNGX): 'We have been consistently bullish'

Apr 15, 2026 09:05AM Tango Therapeutics names Matthew Gall CFO, adds two executives

Apr 13, 2026 04:09PM Tango Therapeutics Inc. (TNGX) PT Raised to $28 at Leerink Partners

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 2, 2026 05:12AM Canaccord Starts Tango Therapeutics Inc. (TNGX) at Buy

Mar 27, 2026 04:56AM Tango Therapeutics Inc. (TNGX) PT Raised to $21 at B.Riley

Mar 9, 2026 07:55AM Tango Therapeutics Inc. (TNGX) PT Raised to $24 at Stifel After Model Update

Mar 5, 2026 04:46PM Tango Therapeutics Inc. (TNGX) PT Raised to $18 at Jefferies

Mar 5, 2026 10:30AM Stifel Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX) following Q4 results

Mar 5, 2026 07:37AM Tango Therapeutics, Inc. (TNGX) Tops Q4 EPS by 3c

Feb 27, 2026 05:30PM Weakness in this biopharma stock is a buying opportunity: Leerink

Feb 26, 2026 01:25PM Stifel Earlier Defended Tango Therapeutics Inc. (TNGX) Amid 12pct Decline

Feb 23, 2026 04:02AM Mizuho Starts Tango Therapeutics Inc. (TNGX) at Outperform

Jan 12, 2026 08:45AM Tango Therapeutics (TNGX) Reiterated at Buy by Stifel After Pipeline Updates

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 3, 2025 04:06PM Stifel Starts Tango Therapeutics Inc. (TNGX) at Buy

Nov 21, 2025 08:37AM Tango Therapeutics, Inc (TNGX) files mixed shelf

Nov 21, 2025 08:34AM Tango Therapeutics, Inc (TNGX) files for 1.73M share offering by selling stockholders

Nov 4, 2025 09:04AM Tango Therapeutics, Inc. (TNGX) Misses Q3 EPS by 7c

Oct 27, 2025 06:44AM Tango Therapeutics Inc.'s (TNGX) Vopimetostat Efficacy Impressive: Cantor Fitzgerald

Oct 24, 2025 06:42AM Tango Therapeutics Inc. (TNGX) PT Raised to $12 at Guggenheim

Oct 23, 2025 11:39AM Tango Therapeutics Inc. (TNGX) PT Raised to $15 at Wedbush

Oct 23, 2025 07:25AM Tango Therapeutics raises $225 million in stock offering

Aug 25, 2025 04:09PM Tango Therapeutics chief legal officer resigns to pursue new opportunity

Aug 19, 2025 06:18AM Piper Sandler Starts Tango Therapeutics Inc. (TNGX) at Overweight

Aug 5, 2025 07:04AM Tango Therapeutics, Inc. (TNGX) Reports In-Line Q2 EPS

Jun 30, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)

Jun 27, 2025 07:03AM Tango Therapeutics (TNGX) Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lun

May 21, 2025 07:01AM Tango Therapeutics, Inc (TNGX) Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors

May 12, 2025 07:04AM Tango Therapeutics, Inc. (TNGX) Reports In-Line Q1 EPS

Apr 14, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)

Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'

Nov 6, 2024 07:15AM Tango Therapeutics, Inc. (TNGX) Tops Q3 EPS by 10c

Nov 6, 2024 07:11AM Tango Therapeutics, Inc. (TNGX) Tops Q3 EPS by 10c

Nov 6, 2024 07:02AM Tango Therapeutics, Inc (TNGX) Reports Positive TNG462 Clinical Data, Provides Update on PRMT5 Development Program

Oct 28, 2024 07:29AM H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)

Oct 15, 2024 05:59AM Leerink Partners Reiterates Outperform Rating on Tango Therapeutics Inc. (TNGX)

Sep 17, 2024 07:20AM Piper Sandler Reiterates Overweight Rating on Tango Therapeutics Inc. (TNGX)

Sep 10, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)

Sep 9, 2024 07:37AM Piper Sandler Reiterates Overweight Rating on Tango Therapeutics Inc. (TNGX)

Jul 17, 2024 02:21AM Jefferies Starts Tango Therapeutics Inc. (TNGX) at Buy

View Older Stories